HIV co-infection accelerates decay of humoral responses in spontaneous resolvers of HCV infection

Journal of Viral Hepatitis

Volumn 21, Issue 10, 2014, Pages 690-695

  Liu, Y ^a,b   Shen, T ^a,c   Zhang, C ^d   Long, L ^a   Duan, Z ^a   Lu, F ^a,c  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b ZHENGZHOU UNIVERSITY   (China)

^c PEKING UNIVERSITY   (China)

^d PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

anti HCV antibodies; CD4+T counts; HCV; HIV; spontaneous recovery

Indexed keywords

HEPATITIS C ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; MIXED INFECTION; YOUNG ADULT; BLOOD; COMPLICATION; FEMALE; FOLLOW UP; IMMUNOLOGY; MALE; TIME;

ADULT; COINFECTION; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV INFECTIONS; HUMANS; MALE; TIME FACTORS;

EID: 84908213617     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12238     Document Type: Article

References (14)

1. Marcellin P,. Hepatitis C: the clinical spectrum of the disease. J Hepatol 1999; 31 (Suppl 1): 9-16.
2. Pestka JM, Zeisel MB, Blaser E, et al,. Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C. Proc Natl Acad Sci USA 2007; 104: 6025-6030.
3. Wang CC, Krantz E, Klarquist J, et al,. Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance. J Infect Dis 2007; 196: 1474-1482.
4. Takaki A, Wiese M, Maertens G, et al,. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med 2000; 6: 578-582.
5. Van den Berg CH, Grady BP, Schinkel J, et al,. Female sex and IL28B, a synergism for spontaneous viral clearance in hepatitis C virus (HCV) seroconverters from a community-based cohort. PLoS ONE 2011; 6: e27555.
6. Rao HY, Sun DG, Jiang D, et al,. IL28B genetic variants and gender are associated with spontaneous clearance of hepatitis C virus infection. J Viral Hepat 2012; 19: 173-181.
7. Grebely J, Raffa JD, Lai C, Krajden M, Conway B, Tyndall MW,. Factors associated with spontaneous clearance of hepatitis C virus among illicit drug users. Can J Gastroenterol 2007; 21: 447-451.
8. Zhang W, Hu D, Xi Y, Zhang M, Duan G,. Spread of HIV in one village in central China with a high prevalence rate of blood-borne AIDS. Int J Infect Dis 2006; 10: 475-480.
9. Liu J, Chen X, Xie Q, et al,. Drug resistance and HCV coinfection in former blood donors infected with HIV type 1 in China. AIDS Res Hum Retroviruses 2011; 27: 925-930.
10. Shen T, Chen X, Zhang W, et al,. A higher correlation of HCV core antigen with CD4+ T cell counts compared with HCV RNA in HCV/HIV-1 coinfected patients. PLoS ONE 2011; 6: e23550.
11. Wiens BL, Bohidar NR, Pigeon JG, et al,. Duration of protection from clinical hepatitis A disease after vaccination with VAQTA. J Med Virol 1996; 49: 235-241.
12. Kerneis S, Desaint C, Brichler S, et al,. Long-term persistence of humoral immunity after hepatitis A vaccination in HIV-infected adults. J Acquir Immune Defic Syndr 2011; 57: e63-e66.
13. Hammitt LL, Bulkow L, Hennessy TW, et al,. Persistence of antibody to hepatitis A virus 10 years after vaccination among children and adults. J Infect Dis 2008; 198: 1776-1782.
14. Fraser C, Tomassini JE, Xi L, et al,. Modeling the long-term antibody response of a human papillomavirus (HPV) virus-like particle (VLP) type 16 prophylactic vaccine. Vaccine 2007; 25: 4324-4333.